ELDN logo

Eledon Pharmaceuticals (ELDN) Price To Book Ratio

PB Ratio

3.79
+0.06+1.61%

3 min ago


Summary


Performance

ELDN PB Ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherELDNvaluationmetrics:

PB Ratio Formula

P/B =  
Price
Quarterly Book Value

ELDN PB Ratio Trends

PeriodPeriodPB ratioPB ratioPricePriceMarket capMarket capPE ratioPE ratio
todaytoday+1.6%+1.5%+1.5%-
1 m1 month-0.3%-0.4%-0.4%-
3 m3 months-3.3%-3.4%-3.4%-
6 m6 months+131.9%+84.1%+185.6%-
ytdytd+17.0%+17.1%+17.1%-
1 y1 year-35.9%+174.0%+576.0%-
5 y5 years+474.2%-44.2%+4528.6%-

ELDN PB Ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-0.3%2.91+30.2%
3 m3-month4.08-7.1%2.91+30.2%
6 m6-month4.21-10.0%-13.99+127.1%
1 y1-year7.57-49.9%-14.31+126.5%
3 y3-year7.57-49.9%-14.31+126.5%
5 y5-year7.57-49.9%-14.31+126.5%
alltimeall time26.30-85.6%-14.31+126.5%

Eledon Pharmaceuticals PB Ratio History

DateValue
2025
3.79(+17.0%)
2024
3.24(-46.4%)
2023
6.05(+1535.1%)
2022
0.37(-2.6%)
2021
0.38(-68.9%)
2020
1.22(+54.4%)
DateValue
2019
0.79(-24.0%)
2018
1.04(-29.7%)
2017
1.48(-120.1%)
2016
-7.35(-330.4%)
2015
3.19(0.0%)
2014
3.19

FAQ

  • What is Eledon Pharmaceuticals price to book ratio?
  • What is the all time high PB ratio for Eledon Pharmaceuticals?
  • What is ELDN price to book ratio year-to-date change?
  • What is Eledon Pharmaceuticals PB ratio year-on-year change?

What is Eledon Pharmaceuticals price to book ratio?

The current PB ratio of ELDN is 3.79

What is the all time high PB ratio for Eledon Pharmaceuticals?

Eledon Pharmaceuticals all-time high price to book ratio is 26.30

What is ELDN price to book ratio year-to-date change?

Eledon Pharmaceuticals price to book ratio has changed by +0.55 (+16.98%) since the beginning of the year

What is Eledon Pharmaceuticals PB ratio year-on-year change?

Over the past year, ELDN price to book ratio has changed by -2.12 (-35.87%)